Samer Salah

8PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyPharmacogenomicsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 18, 2025
Assessing Response Durability and Survival After Second-Line Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Validation of a Risk Model.

Samer Salah, Katsuhiro Ito, Yuki Kita

|Feb 21, 2025
Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience.

Mimma Rizzo, Franco Morelli, Yüksel Ürün

|Sep 12, 2024
Comprehensive Analysis of Metastatic Prostate Cancer: Real-World Data From the Middle East.

Ramiz Abu-Hijlih, Samer Salah, Haneen Abaza

|Jun 19, 2024
From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer.

Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Deya' Aldeen Sweedat

|Jan 03, 2024
A Rare Case of Nasal Sarcoma with BCOR Internal Tandem Duplication Showing Complete Pathologic Response to the VDC-IE Chemotherapy Protocol.

Samer Salah, Maher A Sughayer, Omar Jaber

|Jul 21, 2022
Bone marrow involvement in patients with metastatic castration sensitive prostate cancer.

Mohammed Shahait, Ramiz Abu-Hijlih, Alaa Salamat

Pageof 2

Frequent Collaborators

3 joint publications

Ramiz Abu-Hijlih

2 joint publications

Akram Al-Ibraheem

1 joint publications

Faris Tamimi

1 joint publications

Mohammed Shahait